Innes James, Ugochukwu Uju, Trenholm Julie, Boswell Leo
Norfolk and Suffolk NHS Foundation Trust, Norwich, UK
Norfolk and Suffolk NHS Foundation Trust, Norwich, UK.
BMJ Open Qual. 2025 Feb 25;14(1):e003094. doi: 10.1136/bmjoq-2024-003094.
Psychotropic medicines are commonly prescribed as when required (PRN) prescriptions for inpatients for anxiety, insomnia or as part of a strategy to de-escalate situations that may lead to violence and aggression. While these medicines can provide benefit, safeguards need to be in place to ensure they are regularly reviewed and not overused.
To (1) establish baseline practice around the clinical review of psychotropic PRN medicines for inpatients and (2) improve clinical practice around the clinical review of PRN medicines from baseline and the end of the improvement programme.Centrally coordinated, locally driven, improvement programme taking place over a 5-month period between February and June 2024. The programme employed a learning system approach to enable doctors to test change ideas and share areas of good practice as they sought to understand the problem, test different approaches and focus on holding the gains.
21 wards participated and at an aggregate level achieved both aims with the recording of clinical reviews in the notes increasing from 89% to 90% and the quality of what was recorded in the notes increasing from 51% to 72%. There were signs of increased adjustments to psychotropic PRN medicines during the programme and in some wards decreased rates of psychotropic PRN administration to patients. However, while overall levels of psychotropic PRN medicine administration benchmarked lower than those reported in other studies, there were significant differences in clinical reviews, prescription and administration rates between a group of wards that fully engaged and partially engaged in the improvement programme.
Employing a learning system approach helped create a context suitable for improvement and led to improvements in the review of psychotropic PRN medicines. Exploring the variation between wards in fully engaged and partially engaged groups of wards could be a next step for the Trust.
精神药物通常以按需(PRN)处方的形式开给住院患者,用于治疗焦虑、失眠,或作为缓和可能导致暴力和攻击行为的局势的策略的一部分。虽然这些药物可能有益,但需要有保障措施来确保对其进行定期审查且不过度使用。
(1)围绕住院患者精神药物按需处方的临床审查建立基线实践;(2)从基线水平和改进计划结束时起,改进围绕按需处方临床审查的临床实践。2024年2月至6月期间,在5个月内开展了由中央协调、地方推动的改进计划。该计划采用学习系统方法,使医生能够在试图理解问题、测试不同方法并专注于保持成果时,检验变革想法并分享良好实践领域。
21个病房参与其中,总体上实现了两个目标,病历中临床审查记录从89%增加到90%,病历记录的质量从51%提高到72%。在该计划期间,有迹象表明对精神药物按需处方的调整有所增加,在一些病房,给予患者精神药物按需处方的比例有所下降。然而,虽然精神药物按需处方的总体给药水平低于其他研究报告的水平,但在完全参与和部分参与改进计划的一组病房之间,临床审查、处方和给药率存在显著差异。
采用学习系统方法有助于营造适合改进的环境,并导致精神药物按需处方审查方面的改进。探索完全参与和部分参与的病房组之间的差异可能是该信托机构的下一步行动。